Literature DB >> 2500402

Hemodialysis in the treatment of lactic acidosis in diabetics treated by metformin: a study of metformin elimination.

J D Lalau1, M Andrejak, P Morinière, B Coevoet, X Debussche, P F Westeel, A Fournier, J Quichaud.   

Abstract

The aim of this study was to determine the characteristics of metformin elimination by dialysis. For this purpose we report the kinetic parameters during dialysis and the metformin clearance (i.e. dialysance) in four patients presenting with lactic acidosis which occurred on metformin therapy. We also studied metformin elimination in two chronically hemodialyzed diabetic patients inadvertently maintained on metformin therapy and in two chronically hemodialyzed non-diabetic patients who took a single dose of metformin before a dialysis session. Analysis of plasma concentration-time curves showed a biphasic pattern of metformin - elimination, according to a two-compartment model. We demonstrate that metformin may be removed even after reaching an equilibrium between blood and dialysate levels in a recirculating system, suggesting a storage of metformin in a deep compartment with a gradient of concentration between this compartment and the blood. Lastly, metformin dialysance appears satisfactory (68 ml/min) even in the case of relatively low blood flow; this value reached 170 ml/min under good hemodynamic conditions. In conclusion, hemodialysis efficiently removes metformin and corrects metabolic acidosis in patients with metformin-induced lactic acidosis.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2500402

Source DB:  PubMed          Journal:  Int J Clin Pharmacol Ther Toxicol        ISSN: 0174-4879


  24 in total

1.  Toxicokinetics of metformin-associated lactic acidosis with continuous renal replacement therapy.

Authors:  Muhammad Mujtaba; Abdallah Sassine Geara; Machaiah Madhrira; Rajesh Agarwala; Herman Anderson; Jen-Tse Cheng; Sumit Mohan
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2012-08-29       Impact factor: 2.441

Review 2.  A risk-benefit assessment of metformin in type 2 diabetes mellitus.

Authors:  H C Howlett; C J Bailey
Journal:  Drug Saf       Date:  1999-06       Impact factor: 5.606

3.  Lactic acidosis in metformin therapy.

Authors:  J D Lalau; J M Race
Journal:  Drugs       Date:  1999       Impact factor: 9.546

4.  Is the use of metformin in patients undergoing dialysis hazardous for life? A systematic review of the safety of metformin in patients undergoing dialysis.

Authors:  Christina Abdel Shaheed; Jane E Carland; Garry G Graham; Sophie L Stocker; Greg Smith; Mark Hicks; Kenneth M Williams; Timothy Furlong; Peter Macdonald; Jerry R Greenfield; Felicity C Smith; Gina Chowdhury; Richard O Day
Journal:  Br J Clin Pharmacol       Date:  2019-12-09       Impact factor: 4.335

Review 5.  Clinical pharmacokinetics of metformin.

Authors:  A J Scheen
Journal:  Clin Pharmacokinet       Date:  1996-05       Impact factor: 6.447

6.  Metformin in peritoneal dialysis: a pilot experience.

Authors:  Abdulla Khalaf Al-Hwiesh; Ibrahiem Saeed Abdul-Rahman; Mohammad Ahmad Nasr El-Deen; Emmanuel Larbi; Jose C Divino-Filho; Fahd Abdul-Aziz Al-Mohanna; Krishan L Gupta
Journal:  Perit Dial Int       Date:  2014-03-01       Impact factor: 1.756

7.  The pharmacokinetics of metformin in patients receiving intermittent haemodialysis.

Authors:  Klarissa A Sinnappah; Isabelle H S Kuan; Tilenka R J Thynne; Matthew P Doogue; Daniel F B Wright
Journal:  Br J Clin Pharmacol       Date:  2020-02-25       Impact factor: 4.335

8.  Lactic Acidosis in a Patient with Type 2 Diabetes Mellitus.

Authors:  Lawrence S Weisberg
Journal:  Clin J Am Soc Nephrol       Date:  2015-03-11       Impact factor: 8.237

Review 9.  Management of antidiabetic medications in overdose.

Authors:  H A Spiller
Journal:  Drug Saf       Date:  1998-11       Impact factor: 5.606

10.  Impact of acute kidney injury on metformin-associated lactic acidosis.

Authors:  Yao-Ko Wen
Journal:  Int Urol Nephrol       Date:  2009-03-12       Impact factor: 2.370

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.